Skip to main content
. 2013 Mar 12;15(6):727–734. doi: 10.1093/neuonc/not012

Fig. 3.

Fig. 3.

(A) OS according to the presence of APVT and RPVI in patients with PCNS-DLBCL. Patients with RPVI-positive lymphomas (green line) showed significantly better survival rates, compared with patients with APVT-positive lymphomas (red line). (B) OS associated with XBP1 and CD44 staining in patients with PCNS-DLBCL. Patients with XBP1 and CD44-positive lymphomas (yellow line) showed significantly worse survival rates, compared with patients with XBP1 and CD44-negative lymphomas (green line).